Bio Blast Pharma Aktie
0,77
EUR
-0,09
EUR
-9,94
%
0,89
USD
-0,09
USD
-9,42
%
Werbung
Bio Blast Pharma Aktie Analyse
28.01.16 | Bio Blast Pharma Buy | Rodman & Renshaw, LLC | |
09.12.15 | Bio Blast Pharma Buy | ROTH Capital Partners, LLC | |
15.06.15 | Bio Blast Pharma Buy | ROTH Capital Partners, LLC | |
08.01.15 | Bio Blast Pharma Buy | ROTH Capital Partners, LLC |
Werbung
Werbung